Capillary hyperpermeability
|
disease |
|
Disease or Syndrome
|
5
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Mirizzi Syndrome
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
6
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Chromosome 2q37 deletion syndrome
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
9
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Left Bundle-Branch Block
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
25
|
1
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2020 |
Hyperlipoproteinemia Type I
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
36
|
64
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Fibrinogen assay
|
phenotype |
|
Laboratory Procedure
|
55
|
143
|
0.100 |
None |
1.000 |
2 |
1
|
2016 |
2017 |
Regurgitation
|
phenotype |
|
Sign or Symptom
|
66
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Meningitis, Bacterial
|
group |
Infections; Nervous System Diseases
|
Disease or Syndrome
|
81
|
16
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Chronic small plaque psoriasis
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
82
|
3
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2019 |
Inflammatory Myofibroblastic Tumor
|
disease |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
92
|
2
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Abscess
|
phenotype |
Pathological Conditions, Signs and Symptoms; Infections
|
Disease or Syndrome
|
96
|
1
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Hepatocellular Adenoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
114
|
7
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Small Lymphocytic Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
120
|
122
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Toxic Epidermal Necrolysis
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders; Stomatognathic Diseases
|
Disease or Syndrome
|
143
|
29
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Tonometry
|
phenotype |
|
Diagnostic Procedure
|
206
|
573
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Erythema
|
phenotype |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
227
|
8
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Smoking Behaviors
|
phenotype |
Behavior and Behavior Mechanisms
|
Individual Behavior
|
249
|
742
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Coinfection
|
phenotype |
Infections
|
Disease or Syndrome
|
252
|
11
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Brain Ischemia
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
358
|
5
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Smoking
|
phenotype |
Behavior and Behavior Mechanisms
|
Individual Behavior
|
391
|
765
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Intrahepatic Cholangiocarcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
470
|
19
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Noninfiltrating Intraductal Carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
486
|
13
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Influenza A
|
disease |
|
Disease or Syndrome
|
563
|
19
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Graves Disease
|
disease |
Eye Diseases; Immune System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
585
|
352
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Eosinophil count procedure
|
phenotype |
|
Laboratory Procedure
|
610
|
1144
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |